Trends in Glycoscience and Glycotechnology
Online ISSN : 1883-2113
Print ISSN : 0915-7352
ISSN-L : 0915-7352
MINIREVIEW (Jpn. Ed.)
Versican and Versikine: Regulator of Matrix Dynamism
Hideto Watanabe
Author information
JOURNAL RESTRICTED ACCESS

2024 Volume 36 Issue 212 Pages J61-J64

Details
Abstract

Versican is a large chondroitin sulfate proteoglycan in the extracellular matrix (ECM). In adults, it is constitutively expressed in large arteries and the brain, serving as a structural macromolecule of the ECM. In embryos, it is transiently expressed at high levels in the developing heart, cartilage primordium, dermis, and hair follicles. In the inflammation and cancer invasion, versican is transiently expressed in the stroma. There, versican plays a major role in forming a “provisional matrix.” When the provisional matrix is replaced by the authentic extracellular matrix that should be, transiently expressed versican is primarily degraded by A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS)-1, 4, 5, 9, 15, 20 15, 20, and an N-terminal cleaved fragment serves as a bioactive molecule, thereby termed versikine. This paper reviews the biological functions of versican and its degradation products.

Content from these authors
© 2024 FCCA (Forum: Carbohydrates Coming of Age)
Previous article Next article
feedback
Top